共 9 条
[1]
A double-blind, randomized,placebo-controlled trial of itraconazole capsules as antifungal prophylaxis for neutropenic patients. Nucci M,Biasoli I,Akiti T,et al. Clinical Infectious Diseases . 2000
[2]
Nosocomial fungemia: a 2year prospective study. Costa SF,Marinho I,Araujo EA,et al. Journal of Hospital Infection . 2000
[3]
Difinitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis.The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Bone RC,Balk RA,Gerra FB,et al. Chest . 1992
[4]
Microwave-stimulated JonesMarres method for staining fungi in brain tissue of immunocompromised patients. Boon ME,Barlow Y,Marres EM,et al. Methods . 1998
[5]
Combination therapy with amphotericin B and fluconazole against invasive candidiasis in neutropenic-mouse and infective-endocarditis rabbit models. Sanati H,Ramos CF,Bayer AS,et al. Antimicrobial Agents and Chemotherapy . 1997
[6]
Efficacies of high-dose fluconazole plus amphotericin B and high-dose fluconazole plus 5-fluorocytosine versus amphotericin B, fluconazole, and 5-flurocytosine monotherapies in treatment of experimental endocarditis, endophthalmitis, and pyelonephritis du. Louie A,Liu W,Miller DA,et al. Antimicrobial Agents and Chemotherapy . 1999
[7]
ArandomizedstudycomparingfluconazolewithamphotericinB/5 flucytosineforthetreatmentofsystemicCandidainfectionsinintensivecarepatients. AbeleHornM,KoppA,SternbergU,etal. Journal of Infection . 1996
[8]
Analysis by pulsed-field gel electrophoresis of Candida albicans that developed resistance during antifungal therapy. Mori T,Matsumura M,Oguri T. Japanese Journal of Medical Mycology . 1998
[9]
Trichosporon beigelii infection: experience in a regional burn center. Cawley MJ,Braxton GR,Haith LR,et al. Burns . 2000